超声腺体组织成分:BI-RADS 4A 乳腺肿块升级的潜在影像标志物
该研究回顾了2020年1月至12月经超声和病理证实的319例BI-RADS 4A乳腺肿块患者,将超声腺体组织成分(GTC)分为GTC-Low和GTC-High。GTC-High组恶性率(32.7%,16/49)显著高于总体队列(14.1%,45/319;P=0.001);倾向性评分匹配后,GTC-High组恶性率(35.6%,16/45)显著高于GTC-Low组(13.3%,6/45;P=0.014)。结论认为超声GTC是BI-RADS 4A乳腺肿块恶性的独立预测因子,GTC-High的4A肿块可能需重新分类为4B。
要点
- 超声GTC-High的BI-RADS 4A乳腺肿块恶性率显著高于GTC-Low(匹配后35.6% vs 13.3%,P=0.014)。
- GTC分类在两位放射科医师间一致性良好(加权kappa:0.736/0.716)。
- 超声GTC是BI-RADS 4A乳腺肿块恶性的独立预测因子(匹配后多因素logistic回归P=0.012)。
核心结论
- 超声GTC是BI-RADS 4A乳腺肿块恶性的独立预测因子;最初分类为BI-RADS 4A的肿块在识别为GTC-High时可能需重新分类为BI-RADS 4B。
研究设计与样本
- 回顾性研究,最终纳入319例经超声和病理证实的BI-RADS 4A乳腺肿块患者,基于常规乳腺超声图像将GTC分为GTC-Low和GTC-High,采用kappa检验评估两位放射科医师分类一致性,应用倾向性评分匹配调整两组间不平衡特征,采用logistic回归分析GTC与肿块良恶性的关系。
诊断标准与关键数值
- GTC-High组恶性率32.7%(16/49)显著高于总体队列14.1%(45/319),P=0.001。
- 倾向性评分匹配后,GTC-High组恶性率35.6%(16/45)显著高于GTC-Low组13.3%(6/45),P=0.014。
- 匹配后单因素和多因素logistic回归分析显示超声GTC是与BI-RADS 4A肿块恶性相关的独立变量,P=0.012。
- 两位放射科医师GTC分类一致性良好,加权kappa为0.736/0.716。
临床应用与阅片要点
- 作者认为,最初分类为BI-RADS 4A的乳腺肿块在识别为GTC-High时可能需重新分类为BI-RADS 4B。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: To investigate whether sonographic glandular tissue component (GTC) can optimize the management of breast imaging reporting and data system (BI-RADS) 4A breast masses.
MATERIALS AND METHODS: We reviewed the patients with BI-RADS 4A breast masses confirmed by ultrasound and pathology reports from January to December 2020. Based on conventional breast ultrasound images, GTC was categorized into GTC-Low and GTC-High. The consistency of the GTC classification between two radiologists was evaluated using a kappa test. Propensity score matching (PSM) was applied to adjust for unbalanced characteristics between the two groups. Logistic regression was used to analyze the relationship between sonographic GTC and the likelihood of BI-RADS 4A masses being benign or malignant.
RESULTS: Of the 319 patients included finally in the study, the agreement between the two radiologists regarding the GTC classification was good (weighted kappa: 0.736/0.716). The malignancy rate in the GTC-High group (32.7%, 16/49) was significantly higher than that in the overall cohort (14.1%, 45/319; P=0.001). After PSM adjustment to balance relevant covariates between the GTC-High and GTC-Low groups, 45 GTC-High patients were matched with 45 GTC-Low patients. After matching, univariate and multivariate logistic regression analyses identified sonographic GTC as an independent variable associated with malignancy in BI-RADS 4A masses (P=0.012). After matching, the malignancy rate in the GTC-High group (35.6%,16/45) was significantly higher (P=0.014) than that in the GTC-Low group (13.3%, 6/45).
CONCLUSION: Sonographic GTC is an independent predictor of malignancy in BI-RADS 4A breast masses. Masses initially classified as BI-RADS 4A may warrant reclassification to BI-RADS 4B when identified as GTC-High.
引用
- Zhong Y, Chen YT, Qiu YD, et al. Sonographic Glandular Tissue Component: A Potential Imaging Marker for Upgrading BI-RADS 4A Breast Masses. Acad Radiol. 2025. PMID: 40210518. doi:10.1016/j.acra.2025.03.041
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。